SEC 13F Intelligence

Rock Springs Capital Management LP / CHRS

Rock Springs Capital Management LP’s Coherus Oncology Inc Position

Does Rock Springs Capital Management LP own Coherus Oncology Inc (CHRS)? Not currently — the last reported position was 1.16M shares worth $20M in Q4 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$20M
Q4 2020
Shares
1.16M
% of Portfolio
+0.43%
Quarters Held
9
position exited

Position History CHRS

Reported value by quarter
Q4 ’18: $6MQ4 ’18Q1 ’19: $9MQ2 ’19: $42MQ2 ’19Q3 ’19: $38MQ4 ’19: $35MQ4 ’19Q1 ’20: $32MQ2 ’20: $36MQ2 ’20Q3 ’20: $31MQ4 ’20: $20MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20201.16M$20M+0.43%
Q3 20201.67M$31M+0.77%
Q2 20202.03M$36M+0.99%
Q1 20201.95M$32M+1.31%
Q4 20191.95M$35M+1.11%
Q3 20191.88M$38M+1.52%
Q2 20191.88M$42M+1.50%
Q1 2019670.0K$9M+0.35%
Q4 2018670.0K$6M+0.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of CHRS.